athenahealth Company Profile (NASDAQ:ATHN)

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Software & Technology Services
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:ATHN
  • CUSIP: 04685W10
  • Web:
  • Market Cap: $4.93774 billion
  • Outstanding Shares: 39,929,000
Average Prices:
  • 50 Day Moving Avg: $138.24
  • 200 Day Moving Avg: $129.15
  • 52 Week Range: $90.11 - $158.66
  • Trailing P/E Ratio: 156.93
  • Foreward P/E Ratio: 90.93
  • P/E Growth: 3.20
Sales & Book Value:
  • Annual Revenue: $1.15 billion
  • Price / Sales: 4.29
  • Book Value: $17.97 per share
  • Price / Book: 6.88
  • EBIDTA: $127.7 million
  • Net Margins: 3.29%
  • Return on Equity: 5.65%
  • Return on Assets: 3.24%
  • Debt-to-Equity Ratio: 0.37%
  • Current Ratio: 1.62%
  • Quick Ratio: 1.62%
  • Average Volume: 543,312 shs.
  • Beta: 1.79
  • Short Ratio: 8.74

Frequently Asked Questions for athenahealth (NASDAQ:ATHN)

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth, Inc (NASDAQ:ATHN) posted its earnings results on Thursday, July, 20th. The company reported $0.51 EPS for the quarter, beating the Zacks' consensus estimate of $0.39 by $0.12. The company had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a return on equity of 5.65% and a net margin of 3.29%. The company's revenue for the quarter was up 15.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.34 earnings per share. View athenahealth's Earnings History.

When will athenahealth make its next earnings announcement?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, October, 18th 2017. View Earnings Estimates for athenahealth.

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2017?

24 brokers have issued 1-year price objectives for athenahealth's shares. Their predictions range from $88.00 to $190.00. On average, they anticipate athenahealth's stock price to reach $148.77 in the next year. View Analyst Ratings for athenahealth.

What are analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • 1. Cantor Fitzgerald analysts commented, "It is difficult to predict what the ultimate outcome will be given the Elliott stake. Over the years, ATHN has typically invested for longer-term growth, which has often resulted in inconsistent quarterly performance. After a bumpy roll-out of the streamlined platform last year, we believe performance has improved. Also, the company’s investment in the small hospital market is moving along better than we originally expected. We maintain our view that the company can help physician offices transition to value-based reimbursement and increase its population health offerings. It remains to be seen if athena can enhance the functionality of its hospital offering to move into larger hospitals. Still, athena continues to have a significant presence in the ambulatory market, and it should be able to better leverage its capabilities over time. Praxify Techologies acquisition reflects another long-term investment. On June 7, ATHN announced that it acquired privately-held Praxify Technologies for $63 million in cash. We characterize this acquisition as a technology acquisition which should help the company add app-layer technology to its ambulatory and inpatient products. We assume the acquisition will be dilutive in the near term but help the company’s long-term product performance. Basis for higher price target. With the filing by Elliott, we increased our DCF-based price target to $140." (6/13/2017)
  • 2. Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • 3. Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)

Who are some of athenahealth's key competitors?

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

  • Jonathan S. Bush, Chairman of the Board, President, Chief Executive Officer
  • John A. Kane, Interim Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer, Director
  • Stephen N. Kahane M.D., Executive Vice President ; President - Client Organisation
  • Prakash Khot, Senior Vice President, Chief Technology Officer
  • Timothy O'Brien, Senior Vice President, Chief Marketing Officer
  • Dan Haley, Senior Vice President, General Counsel, Secretary
  • Kyle Armbrester, Senior Vice President, Chief Product Officer
  • Brandon H. Hull, Lead Independent Director
  • Brian P. McKeon, Director
  • Thomas J. Szkutak, Director

Who owns athenahealth stock?

athenahealth's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (14.96%), Janus Henderson Group PLC (12.72%), Vanguard Group Inc. (7.77%), Capital Research Global Investors (5.11%), BlackRock Inc. (4.09%) and Riverbridge Partners LLC (2.60%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis, Kristi Ann Matus, Robert Cosinuke, Stephen N Kahane and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Franklin Resources Inc., Macquarie Group Ltd., Jackson Square Partners LLC, Stephens Investment Management Group LLC, PDT Partners LLC, New York State Common Retirement Fund and Bank of Montreal Can. Company insiders that have sold athenahealth stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter and Karl Stubelis. View Insider Buying and Selling for athenahealth.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Elliott Management Corp, Capital Research Global Investors, Nikko Asset Management Americas Inc., Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Balyasny Asset Management LLC and Vanguard Group Inc.. View Insider Buying and Selling for athenahealth.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of athenahealth stock can currently be purchased for approximately $123.66.

MarketBeat Community Rating for athenahealth (NASDAQ ATHN)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  459 (Vote Outperform)
Underperform Votes:  526 (Vote Underperform)
Total Votes:  985
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for athenahealth (NASDAQ:ATHN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 11 Hold Ratings, 11 Buy Ratings
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $148.77 (20.31% upside)

Analysts' Ratings History for athenahealth (NASDAQ:ATHN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$153.00MediumView Rating Details
9/17/2017KeyCorpReiterated RatingBuy$170.00MediumView Rating Details
9/15/2017Jefferies Group LLCLower Price TargetHold$135.00 -> $120.00LowView Rating Details
8/31/2017Robert W. BairdReiterated RatingBuy$170.00LowView Rating Details
8/2/2017Morgan StanleyReiterated RatingEqual Weight$108.00 -> $125.00LowView Rating Details
8/2/2017SunTrust Banks, Inc.Reiterated RatingBuy$150.00 -> $170.00LowView Rating Details
7/31/2017Cowen and CompanyDowngradeOutperform -> Market Perform$127.00 -> $133.00MediumView Rating Details
7/24/2017Citigroup Inc.Reiterated RatingBuy$169.00 -> $186.00LowView Rating Details
7/24/2017Leerink SwannReiterated RatingMarket Perform -> Positive$140.00 -> $155.00LowView Rating Details
7/24/2017First AnalysisDowngradeEqual Weight -> Underweight$99.00 -> $125.00LowView Rating Details
7/22/2017Evercore ISIReiterated RatingOutperform$155.00 -> $163.00LowView Rating Details
7/22/2017Wells Fargo & CoReiterated RatingOutperform$130.00 -> $190.00LowView Rating Details
7/21/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$154.00 -> $184.00MediumView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingOverweight$171.00HighView Rating Details
7/21/2017William BlairReiterated RatingMarket PerformMediumView Rating Details
7/19/2017J P Morgan Chase & CoSet Price TargetHold$136.00LowView Rating Details
7/7/2017Dougherty & CoDowngradeBuy -> NeutralHighView Rating Details
7/7/2017ArgusInitiated CoverageHoldHighView Rating Details
6/16/2017Stifel NicolausReiterated RatingHold$106.00 -> $151.00LowView Rating Details
6/13/2017Cantor FitzgeraldDowngradeOverweight -> Neutral$140.00LowView Rating Details
5/1/2017Barclays PLCSet Price TargetUnderweight$97.00 -> $88.00MediumView Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00N/AView Rating Details
2/6/2017Canaccord GenuityReiterated RatingHold$112.00N/AView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00N/AView Rating Details
7/22/2016Deutsche Bank AGDowngradeBuy -> Hold$165.00 -> $147.00N/AView Rating Details
2/8/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$155.00 -> $149.00N/AView Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00N/AView Rating Details
10/23/2015Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$160.00N/AView Rating Details
10/21/2015Avondale PartnersInitiated CoverageMarket Perform$175.00N/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for athenahealth (NASDAQ:ATHN)
Earnings by Quarter for athenahealth (NASDAQ:ATHN)
Earnings History by Quarter for athenahealth (NASDAQ ATHN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/18/2017$0.53N/AView Earnings Details
7/20/2017Q2 2017$0.39$0.51$298.68 million$301.10 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for athenahealth (NASDAQ:ATHN)
2017 EPS Consensus Estimate: $1.14
2018 EPS Consensus Estimate: $1.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.17$0.28$0.23
Q2 20172$0.06$0.34$0.20
Q3 20173$0.20$0.36$0.27
Q4 20172$0.39$0.50$0.45
Q1 20181$0.22$0.22$0.22
Q2 20181$0.33$0.33$0.33
Q3 20181$0.34$0.34$0.34
Q4 20181$0.52$0.52$0.52
(Data provided by Zacks Investment Research)


Dividend History for athenahealth (NASDAQ:ATHN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for athenahealth (NASDAQ:ATHN)
Insider Ownership Percentage: 3.20%
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017Jonathan D. PorterSVPSell300$130.38$39,114.00View SEC Filing  
9/1/2017Brandon H. HullDirectorSell800$140.95$112,760.00View SEC Filing  
9/1/2017Jonathan BushCEOSell4,000$139.77$559,080.00View SEC Filing  
8/15/2017Jonathan D. PorterSVPSell300$142.88$42,864.00View SEC Filing  
8/1/2017Brandon H. HullDirectorSell800$140.01$112,008.00View SEC Filing  
8/1/2017Jonathan BushCEOSell4,000$143.31$573,240.00View SEC Filing  
7/21/2017Jonathan D. PorterSVPSell422$154.00$64,988.00View SEC Filing  
7/17/2017Jonathan D. PorterSVPSell300$143.13$42,939.00View SEC Filing  
7/3/2017Brandon H. HullDirectorSell800$140.81$112,648.00View SEC Filing  
7/3/2017Jonathan BushCEOSell4,000$140.52$562,080.00View SEC Filing  
6/15/2017Jonathan D. PorterSVPSell300$142.27$42,681.00View SEC Filing  
6/5/2017Karl StubelisCFOSell3,952$138.98$549,248.96View SEC Filing  
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.25View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.00View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.00View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.00View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.00View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.87View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.08View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.00View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.75View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.00View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.00View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.00View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.00View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.00View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.00View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.05View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.00View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.00View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.15View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.00View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.95View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.50View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.27View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.28View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.00View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.20View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.75View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.00View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.90View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.00View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.00View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.00View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.00View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.00View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.22View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.00View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.00View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.00View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.00View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.00View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.00View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.00View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.00View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.00View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.00View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.00View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.00View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.00View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.00View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.00View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.00View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.00View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.00View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.00View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.00View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.00View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.00View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.00View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.00View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.00View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for athenahealth (NASDAQ:ATHN)
Latest Headlines for athenahealth (NASDAQ:ATHN)
DateHeadline logoathenahealth, Inc. (ATHN) Earns Sector Perform Rating from Analysts at Royal Bank of Canada - September 19 at 11:32 PM logoNotable Two Hundred Day Moving Average Cross - ATHN - Nasdaq - September 19 at 9:08 PM logoathenahealth, Inc. (ATHN) SVP Sells $39,114.00 in Stock - September 18 at 8:08 PM logoBrokers Issue Forecasts for athenahealth, Inc.'s Q3 2017 Earnings (ATHN) - September 18 at 2:18 AM logoKeyCorp Reaffirms "Buy" Rating for athenahealth, Inc. (ATHN) - September 17 at 9:36 AM logoathenahealth, Inc. (ATHN) Rating Reiterated by Jefferies Group LLC - September 15 at 1:48 PM logoathenahealth, Inc. (ATHN) Given Average Recommendation of "Hold" by Brokerages - September 13 at 10:40 AM logo$311.53 Million in Sales Expected for athenahealth, Inc. (ATHN) This Quarter - September 12 at 9:44 AM logo$0.51 Earnings Per Share Expected for athenahealth, Inc. (ATHN) This Quarter - September 10 at 2:14 PM logoInsider Selling: athenahealth, Inc. (ATHN) Director Sells 800 Shares of Stock - September 6 at 8:50 PM logoInsider Selling: athenahealth, Inc. (ATHN) CEO Sells 4,000 Shares of Stock - September 6 at 7:58 PM logoAthenahealth (ATHN) Appoints Brian McKeon to Board - September 5 at 10:46 PM logoAthenahealth (ATHN) Appoints Brian McKeon to Board - - September 5 at 5:44 PM logoBrian McKeon Joins athenahealth Board of Directors - September 5 at 5:44 PM logoathenahealth's (ATHN) Buy Rating Reaffirmed at Robert W. Baird - September 1 at 2:16 PM logoathenahealth, Inc. – Value Analysis (NASDAQ:ATHN) : August 24, 2017 - August 24 at 9:10 PM logoZacks: Analysts Anticipate athenahealth, Inc. (ATHN) to Post $0.51 EPS - August 23 at 12:08 AM logoathenahealth, Inc. (ATHN) Receives Average Rating of "Hold" from Analysts - August 19 at 10:50 AM logoathenahealth, Inc. (ATHN) SVP Sells $42,864.00 in Stock - August 16 at 9:36 PM logoathenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : August 15, 2017 - August 15 at 5:04 PM logoSee what the IHS Markit Score report has to say about Athenahealth Inc. - August 11 at 4:36 PM logoHead to Head Contrast: athenahealth (ATHN) and Castlight Health, inc. (CSLT) - August 8 at 10:28 AM logoAthenahealth reviewing all facets of business in $100M restructuring; Are Austin jobs at risk? - August 7 at 4:56 PM logo Brokerages Expect athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $311.53 Million - August 6 at 7:10 AM logoZacks: Analysts Expect athenahealth, Inc. (NASDAQ:ATHN) to Announce $0.24 Earnings Per Share - August 4 at 8:26 PM logoKeyCorp Weighs in on athenahealth, Inc.'s FY2018 Earnings (NASDAQ:ATHN) - August 4 at 6:02 PM logoathenahealth, Inc. Forecasted to Post Q3 2017 Earnings of $0.20 Per Share (ATHN) - August 4 at 8:48 AM logoETFs with exposure to athenahealth, Inc. : August 3, 2017 - August 3 at 10:34 PM logoBrandon H. Hull Sells 800 Shares of athenahealth, Inc. (ATHN) Stock - August 3 at 9:04 PM logoathenahealth, Inc. (NASDAQ:ATHN) CEO Sells $573,240.00 in Stock - August 3 at 8:20 PM logoEx-UMKC coach swishes an entrepreneurial deal - August 3 at 5:34 PM logoQ4 2017 EPS Estimates for athenahealth, Inc. (ATHN) Lowered by Analyst - August 3 at 1:24 PM logoAthenahealth (ATHN) Announces Strategic Review of Operational and Financial Strategy, Leadership and Governance - August 2 at 4:55 PM logoAthenahealth's $100 million restructuring could put 500-job Atlanta expansion at risk (SLIDESHOW) - August 2 at 4:55 PM logoathenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : August 2, 2017 - August 2 at 4:55 PM logoathenahealth, Inc. (ATHN) Stock Rating Reaffirmed by Morgan Stanley - August 2 at 2:02 PM logoInvestor Einhorn sees cash burn at Tesla, sticks with short bet - Nasdaq - August 1 at 5:02 PM logoUPDATE: Athenahealth stock surges 4.2% on strategic changes, including $100 mln in cost-saving opportunities - MarketWatch - August 1 at 5:02 PM logoAthenahealth (ATHN) Announces Strategic Review of Operational and Financial Strategy, Leadership and Governance - - August 1 at 5:02 PM logoathenahealth Announces Strategic Initiatives to Drive Increased Levels of Profitable Growth and Enhance Shareholder Value - August 1 at 5:02 PM logoUPDATE: Athenahealth stock surges 4.2% on strategic changes, including $100 mln in cost-saving opportunities - August 1 at 5:02 PM logoAthenahealth to conduct strategic review amid investor pressure - August 1 at 5:02 PM logoAthenahealth Stock Climbs Amid Strategic Review, Management Shakeup - August 1 at 5:02 PM logo[$$] Athenahealth Makes a Shareholder-Backed Shake-Up, Keeping CEO - August 1 at 5:02 PM logo​Athenahealth to make $100M in cost cuts as Bush cedes some control - August 1 at 5:02 PM logoathenahealth (NASDAQ:ATHN) and Castlight Health, inc. (CSLT) Critical Analysis - July 25 at 4:25 PM logoathenahealth, Inc. (NASDAQ:ATHN) Given Consensus Recommendation of "Hold" by Analysts - July 25 at 12:53 PM logoathenahealth, Inc. (NASDAQ:ATHN) Given Buy Rating at Citigroup Inc. - July 24 at 7:14 PM logoAthenahealth Inc. (ATHN) Leaped To A New High On Strong Q2 Earnings - July 24 at 12:56 PM logoEdited Transcript of ATHN earnings conference call or presentation 21-Jul-17 12:00pm GMT - July 24 at 12:56 PM



athenahealth (ATHN) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by Staff